Inside Innovation

The University of Washington has moved up two spots to No. 8 in the latest ranking of Best Global Universities from U.S. News & World

Seattle-based Just – Evotec Biologics received funding from The Bill & Melinda Gates Foundation to seek out and work on new monoclonal antibody (mAb) drugs

Seattle-based biotech company HDT Bio raised $3 million in seed funding to support work on its COVID-19 vaccine candidate that uses a cutting-edge, replicating RNA

Seattle’s Fred Hutchinson Cancer Research Center announced that it is opening a new facility dedicated solely to testing treatments for people who have COVID-19, one

Despite an economic downturn, investment in Seattle’s biotech industry hasn’t slowed down this year. With Athira Pharma’s September IPO that raised $204 million, life science

Seattle-based Phase Genomics announced that it received two National Institutes of Health (NIH) grants totaling $3.9 million over three years. The funding will go towards

Sonoma Biosciences, which splits operations between South San Francisco and Seattle, received $40 million in financing to develop cell therapies for autoimmune diseases. Traditionally used

Silverback Therapeutics announced that it received $85 million in Series C funding, following closely on the heels of a $78.5 million funding round in March

Pharmaceutical company Merck and Bothell, Washington-based Seattle Genetics have formed a partnership to advance two key cancer therapies. The first involves expanding Tukysa, the drug

Gilead Sciences announced it has acquired Immunomedics, a developer of antibody-drug conjugate (ADC) technology used to treat cancers. Immunomedics gained attention with the success of

Following a blockbuster deal with pharmaceutical company Merck, Seattle Genetics released plans to build a $300 million manufacturing facility, two to three times the size

Washington was named the best state to work in during the COVID-19 pandemic, according to a report released by Oxfam America. The study looked at